advertisement

Topcon

Journal of Ocular Pharmacology and Therapeutics 10

Showing records 1 to 10 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Ruangvaravate N
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394
76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Kazemi A
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386
77102 The Association of Socioeconomic Status with Severity of Glaucoma and the Impacts of Both Factors on the Costs of Glaucoma Medications: A Cross-Sectional Study in West Bengal, India
Chakravarti T
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 442-451
76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
McLaren JW
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386
76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Prabhasawat P
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394
76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Kopczynski CC
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386
76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Vachirasakchai V
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394
76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Heah TG
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386
76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Tantimala R
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394
76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Novack GD; Sit AJ
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386

Issue 19-3

Change Issue


advertisement

Oculus